Hebert, A., Schrieber, R., Glaab, D. and Eichenfield, L. 2020. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s77. DOI:https://doi.org/10.25251/skin.4.supp.77.